How to buy Redox Limited (RDX) Shares
Manufactured goods have many ingredients and Redox is a key supplier of these materials to many firms.
Want to start buying RDX shares but not sure how? Follow the steps below to invest in Redox Limited on the ASX.
1. Find a stock trading platform
To buy shares listed in Australia, you'll need to sign up with an investment platform that has access to the ASX. There are a number of share trading platforms in Australia, of which Stake is one.
2. Fund your account
Complete an application with your personal and financial details. Fund your investment account with a bank transfer, debit card or even Apple/Google pay.
3. Search for Redox Limited ($RDX)
Find the share by company name or ticker symbol: $RDX. Do your own research to ensure it is the right investment product for your own circumstances.
4. Choose an order type and buy RDX stock
Buy on any trading day with a market order or use a limit order to delay your purchase of RDX shares until it reaches your desired stock price. Look into dollar cost averaging to spread out your risk, which smooths out buying at consistent intervals.
5. Monitor your investment
Optimise your portfolio by tracking how your stock and the business perform with an eye on the long term. You may be eligible for dividends and shareholder voting rights that affect your stock.
Redox Limited overview
Redox Limited sells various chemicals, ingredients and raw materials to businesses. They provide a catalogue of over 1,000 products linked to industry standards to a global customer base. These are used in manufacturing and creation of final goods sold to customers.
The family owned firm was founded as C&K Industrial Traders in 1965 by Roland Coneliano. It originally functioned as a representative for manufacturers that dealt with importing chemicals from Eastern Europe and selling them onto local distributors. By 2021 they were the 35th largest chemical distributor globally and the 13th biggest in the Asia Pacific region
Their clients cover a wide range of industries. Redox caters to human tastes in terms of food, beverages, health, and personal care. They also provide inputs into the agriculture sector, for animal nutrition and textiles. Final products in construction, detergents, water treatment and rubber also use ingredients from Redox.
The firm has considerable control over its operations and has developed in-house supply chain solutions. In FY 2021, they sold 582,444 tonnes of products and handled 23,031 shipping containers. They’ve also emphasised digitalisation and built the Redebiz software system to share information across teams.
Redox is already a multinational business and they expect future growth to come from overseas markets, in particular the U.S. Sales reached a record high of $1.08b in FY 2022.
They operate in a relatively fragmented industry and the team has identified potential targets for acquisition, which could soon be realised with the funds from the IPO.
It presents a more mature and diversified option than most recently listed firms, but there are no guarantees the private successes will translate into share price growth. They are the first IPO to raise more than $100m for an ASX listing since June 2022. Many hope that Redox signals a positive shift in the market, creating more encouraging conditions for other companies to go public in the second half of 2023.
Redox Limited (RDX) IPO details
Redox Limited has filed its prospectus with the Australian Securities and Investments Commission (ASIC) in order to be listed on the ASX using the ticker symbol RDX. Read more in the Redox Limited prospectus.
ASX code | RDX |
Offer price | $2.55 |
Retail offer opened | 21.06.2023 |
Retail offer closed | 27.06.2023 |
Total number of shares available under the offer | 25,000,000 |
IPO funds raised | $402m |
ASX listing date | 03.07.2023 |
You can take a look at the top shareholders in RDX in this document.
If you're considering investing in the Redox Limited listing or other upcoming IPOs, sign up today.
This article focuses on how to buy specific securities, however, it is not a recommendation to invest in them and should not be taken as financial advice. Do your own research and make your own decisions, or even consider getting advice from a licensed financial adviser before investing.
Megan is a markets analyst at Stake, with 7 years of experience in the world of investing and a Master’s degree in Business and Economics from The University of Sydney Business School. Megan has extensive knowledge of the UK markets, working as an analyst at ARCH Emerging Markets - a UK investment advisory platform focused on private equity. Previously she also worked as an analyst at Australian robo advisor Stockspot, where she researched ASX listed equities and helped construct the company's portfolios.